,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Bladder disorder,6,17103352
1,22.1,Product leakage,6,17103352
2,22.1,Vaginal haemorrhage,6,17103352
3,22.1,Bladder pain,6,17103352
0,22.1,Bone cancer metastatic,6,17103353
1,22.1,Metastases to lymph nodes,6,17103353
2,22.1,Thyroid disorder,6,17103353
0,22.1,Left ventricular hypertrophy,6,17103354
1,22.1,Blood pressure increased,3,17103354
2,22.1,Electrocardiogram QT prolonged,1,17103354
3,22.1,Malignant neoplasm progression,3,17103354
4,22.1,Breast cancer metastatic,3,17103354
5,22.1,Bundle branch block right,6,17103354
0,22.1,Pneumonia,3,17103366
1,22.1,Pneumonitis,2,17103366
0,22.1,Death,,17103381
0,22.1,Autoimmune dermatitis,2,17103418
1,22.1,Immune-mediated hepatitis,6,17103418
2,22.1,Myasthenia gravis,2,17103418
3,22.1,Autoimmune myocarditis,6,17103418
0,22.1,Hypoxia,,17103425
0,22.1,Cardiac disorder,6,17103444
0,22.1,Death,,17103491
0,22.1,Rheumatoid arthritis,2,17103508
1,22.1,Sjogren^s syndrome,2,17103508
0,22.1,Metastases to bone,5,17103526
1,22.1,Prostate cancer,5,17103526
0,22.1,Feeling abnormal,,17103559
1,22.1,Infusion related reaction,,17103559
2,22.1,Dizziness,,17103559
3,22.1,Unresponsive to stimuli,,17103559
0,22.1,Death,5,17103572
0,22.1,Headache,,17103576
1,22.1,Facial paralysis,,17103576
2,22.1,Anaesthesia oral,,17103576
3,22.1,Drug intolerance,,17103576
4,22.1,Magnetic resonance imaging brain abnormal,,17103576
5,22.1,Ageusia,,17103576
6,22.1,Dysarthria,,17103576
0,22.1,Injection site necrosis,2,17103615
1,22.1,Injection site ulcer,2,17103615
2,22.1,Injection site induration,6,17103615
3,22.1,Incorrect route of product administration,6,17103615
0,22.1,Liver disorder,6,17103618
1,22.1,Pancreatitis acute,6,17103618
2,22.1,Erythema,6,17103618
0,22.1,Oral candidiasis,3,17103628
1,22.1,Pain,1,17103628
2,22.1,Bronchitis,5,17103628
3,22.1,Decreased appetite,1,17103628
4,22.1,Sepsis,5,17103628
5,22.1,General physical health deterioration,1,17103628
0,22.1,Blood pressure increased,3,17103667
1,22.1,Gastrooesophageal reflux disease,4,17103667
2,22.1,Proteinuria,3,17103667
3,22.1,Protein urine present,3,17103667
4,22.1,Constipation,4,17103667
5,22.1,Protein total increased,3,17103667
6,22.1,Cataract,6,17103667
7,22.1,Diabetes mellitus,3,17103667
0,22.1,VIth nerve paralysis,3,17103675
0,22.1,General physical health deterioration,1,17103715
0,22.1,Pneumonia,5,17103717
1,22.1,Disease progression,5,17103717
0,22.1,Drug-induced liver injury,1,17103740
1,22.1,Asthenia,6,17103740
0,22.1,Liver disorder,2,17103782
0,22.1,Acute kidney injury,1,17103785
1,22.1,Clostridium difficile infection,1,17103785
2,22.1,Hypovolaemia,1,17103785
3,22.1,Dehydration,1,17103785
4,22.1,Diarrhoea,1,17103785
5,22.1,Mucosal inflammation,1,17103785
6,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,17103785
0,22.1,Death,5,17103798
0,22.1,Interstitial lung disease,5,17103807
0,22.1,Tachycardia,6,17103856
1,22.1,Hyperhidrosis,6,17103856
2,22.1,Hypothyroidism,6,17103856
3,22.1,Urinary tract infection,6,17103856
4,22.1,Hyperthyroidism,6,17103856
0,22.1,Infection,6,17103905
1,22.1,Product use in unapproved indication,6,17103905
0,22.1,Nausea,6,17103909
1,22.1,Prostatic specific antigen increased,6,17103909
2,22.1,Oedema,6,17103909
3,22.1,Muscle spasms,6,17103909
4,22.1,Joint swelling,6,17103909
5,22.1,Dry skin,6,17103909
0,22.1,Alopecia,3,17103923
1,22.1,Movement disorder,6,17103923
0,22.1,Pneumonitis,5,17103931
0,22.1,Liver disorder,1,17103951
1,22.1,Prescribed underdose,6,17103951
0,22.1,Bone marrow failure,2,17103970
0,22.1,Burning sensation,1,17103975
1,22.1,Rash pruritic,1,17103975
2,22.1,Therapeutic response decreased,6,17103975
3,22.1,Abdominal pain upper,1,17103975
0,22.1,Drug hypersensitivity,6,17103980
1,22.1,Toxic leukoencephalopathy,6,17103980
0,22.1,Arrhythmia,2,17103984
1,22.1,Palpitations,2,17103984
2,22.1,Atrial fibrillation,2,17103984
0,22.1,Duodenal ulcer,6,17104011
1,22.1,Adrenocorticotropic hormone deficiency,2,17104011
0,22.1,Death,5,17104056
1,22.1,Peripheral swelling,6,17104056
0,22.1,Muscle spasms,6,17104123
1,22.1,Fatigue,6,17104123
0,22.1,Disease progression,6,17104128
1,22.1,Recurrent cancer,6,17104128
0,22.1,Disease progression,6,17104130
1,22.1,Intentional product misuse,6,17104130
2,22.1,Recurrent cancer,6,17104130
3,22.1,Drug ineffective,6,17104130
0,22.1,Arthritis,3,17104131
1,22.1,Retinal detachment,3,17104131
2,22.1,Depression,1,17104131
3,22.1,Feeling abnormal,1,17104131
4,22.1,Thrombocytopenia,1,17104131
5,22.1,Dyspepsia,6,17104131
6,22.1,Adverse drug reaction,3,17104131
7,22.1,Abdominal discomfort,6,17104131
8,22.1,Arthralgia,3,17104131
9,22.1,Blood count abnormal,1,17104131
10,22.1,Bone pain,6,17104131
11,22.1,Anxiety,1,17104131
0,22.1,Crohn^s disease,3,17104171
1,22.1,Adverse drug reaction,3,17104171
2,22.1,Off label use,6,17104171
0,22.1,Nephritis,2,17104449
1,22.1,Dehydration,2,17104449
0,22.1,Anaphylactic shock,1,17104457
1,22.1,Prescribed underdose,1,17104457
0,22.1,Acute generalised exanthematous pustulosis,1,17104464
0,22.1,Seizure,2,17104715
1,22.1,Extra dose administered,6,17104715
2,22.1,Balance disorder,2,17104715
3,22.1,Off label use,6,17104715
4,22.1,Constipation,3,17104715
5,22.1,Drug interaction,3,17104715
0,22.1,Infusion related reaction,1,17104778
0,22.1,Malignant neoplasm progression,5,17104817
0,22.1,Non-small cell lung cancer,6,17104915
1,22.1,Tinnitus,6,17104915
2,22.1,Product use in unapproved indication,6,17104915
3,22.1,Susac^s syndrome,6,17104915
4,22.1,Vasculitis,6,17104915
5,22.1,Metastases to central nervous system,6,17104915
0,22.1,Death,5,17104921
0,22.1,Pneumonitis,2,17104940
0,22.1,Injection site pain,1,17104944
0,22.1,Off label use,6,17104959
1,22.1,Dry eye,3,17104959
2,22.1,Rash,3,17104959
3,22.1,Dry skin,3,17104959
4,22.1,Paronychia,3,17104959
0,22.1,Pneumothorax,6,17104989
1,22.1,Off label use,6,17104989
2,22.1,Pneumonitis,2,17104989
3,22.1,Rash,1,17104989
0,22.1,Dizziness,6,17105029
1,22.1,Product availability issue,6,17105029
2,22.1,Salivary hypersecretion,6,17105029
3,22.1,Decreased appetite,6,17105029
4,22.1,Asthenia,6,17105029
5,22.1,Fatigue,6,17105029
6,22.1,Kidney infection,6,17105029
7,22.1,Depression,6,17105029
8,22.1,Taste disorder,6,17105029
9,22.1,Nephrolithiasis,6,17105029
0,22.1,Premature baby,6,17105071
1,22.1,Maternal exposure during pregnancy,6,17105071
0,22.1,Pneumonia,3,17105076
1,22.1,Delirium,3,17105076
2,22.1,Metastases to bone,3,17105076
3,22.1,Hepatic function abnormal,3,17105076
0,22.1,Biliary tract infection,1,17105078
1,22.1,Febrile neutropenia,1,17105078
2,22.1,Infection,1,17105078
0,22.1,Drug ineffective,6,17105107
1,22.1,Oestrogen receptor assay positive,6,17105107
2,22.1,Off label use,6,17105107
3,22.1,Pulmonary mass,1,17105107
4,22.1,Intentional product use issue,6,17105107
0,22.1,Myositis,3,17105121
1,22.1,Cardiomyopathy,3,17105121
2,22.1,General physical health deterioration,3,17105121
3,22.1,Transaminases increased,6,17105121
4,22.1,PCO2 increased,3,17105121
5,22.1,Drug ineffective,6,17105121
0,22.1,Alopecia,3,17105132
0,22.1,Anxiety,6,17105147
1,22.1,Pain,6,17105147
2,22.1,Psychological trauma,6,17105147
3,22.1,Emotional distress,6,17105147
4,22.1,Alopecia,2,17105147
5,22.1,Impaired quality of life,6,17105147
0,22.1,Alopecia,3,17105153
1,22.1,Emotional distress,6,17105153
2,22.1,Impaired quality of life,6,17105153
3,22.1,Psychological trauma,6,17105153
4,22.1,Pain,6,17105153
5,22.1,Anxiety,6,17105153
0,22.1,Alopecia,3,17105155
1,22.1,Psychological trauma,6,17105155
0,22.1,Systemic candida,5,17105156
0,22.1,Alopecia,2,17105157
0,22.1,Psychological trauma,6,17105158
1,22.1,Alopecia,2,17105158
0,22.1,Alopecia,3,17105162
1,22.1,Psychological trauma,6,17105162
0,22.1,Emotional distress,6,17105194
1,22.1,Pain,6,17105194
2,22.1,Anxiety,6,17105194
3,22.1,Alopecia,3,17105194
4,22.1,Impaired quality of life,6,17105194
0,22.1,Alopecia,2,17105198
1,22.1,Psychological trauma,6,17105198
0,22.1,Colitis ulcerative,2,17105212
0,22.1,Alopecia,2,17105242
0,22.1,Alopecia,3,17105265
0,22.1,Alopecia,6,17105307
0,22.1,Psychological trauma,6,17105323
1,22.1,Anxiety,3,17105323
2,22.1,Alopecia,2,17105323
0,22.1,Rash,1,17105324
1,22.1,Hypotension,1,17105324
2,22.1,Nausea,1,17105324
3,22.1,Throat tightness,1,17105324
0,22.1,Psychological trauma,6,17105326
1,22.1,Alopecia,2,17105326
0,22.1,Stomatitis,3,17105334
1,22.1,Nail discolouration,3,17105334
2,22.1,Asthenia,3,17105334
3,22.1,Pyrexia,3,17105334
4,22.1,Tachycardia,3,17105334
5,22.1,Diarrhoea,3,17105334
0,22.1,Anaphylactic shock,1,17105350
0,22.1,Psychological trauma,6,17105367
1,22.1,Alopecia,2,17105367
2,22.1,Emotional distress,6,17105367
3,22.1,Pain,6,17105367
4,22.1,Impaired quality of life,6,17105367
5,22.1,Anxiety,6,17105367
0,22.1,Alopecia,3,17105370
1,22.1,Psychological trauma,6,17105370
0,22.1,Emotional distress,6,17105409
1,22.1,Psychological trauma,6,17105409
2,22.1,Anxiety,6,17105409
3,22.1,Impaired quality of life,6,17105409
4,22.1,Pain,6,17105409
5,22.1,Alopecia,3,17105409
0,22.1,Femur fracture,1,17105442
0,22.1,Septic shock,5,17105472
1,22.1,Multiple organ dysfunction syndrome,5,17105472
0,22.1,Acute myeloid leukaemia,6,17105478
0,22.1,Death,5,17105479
0,22.1,Death,5,17105480
0,22.1,Pulmonary haemorrhage,5,17105515
0,22.1,Malignant neoplasm progression,5,17105516
1,22.1,Non-small cell lung cancer,5,17105516
0,22.1,Pneumonia,5,17105573
0,22.1,Acute coronary syndrome,1,17105601
0,22.1,Malaise,1,17105692
1,22.1,Fatigue,1,17105692
2,22.1,Vomiting projectile,1,17105692
0,22.1,Dizziness,6,17105705
1,22.1,Pneumonia,6,17105705
2,22.1,Cough,3,17105705
0,22.1,Liver abscess,1,17105731
1,22.1,Cholangitis,2,17105731
2,22.1,Drug ineffective,6,17105731
0,22.1,Tachycardia,2,17105771
1,22.1,Agitation,2,17105771
2,22.1,Pruritus,2,17105771
3,22.1,Dyspnoea,2,17105771
0,22.1,Recurrent cancer,6,17105803
0,22.1,General physical health deterioration,1,17105805
0,22.1,Disease progression,6,17105809
1,22.1,Recurrent cancer,6,17105809
2,22.1,Drug ineffective,6,17105809
0,22.1,Respiratory failure,5,17105811
1,22.1,Circulatory collapse,5,17105811
0,22.1,Atrial fibrillation,6,17105837
1,22.1,Ejection fraction decreased,6,17105837
0,22.1,Product use in unapproved indication,6,17105838
1,22.1,Disease progression,6,17105838
0,22.1,Neutropenia,6,17105852
1,22.1,Application site discomfort,1,17105852
2,22.1,Wrong technique in product usage process,6,17105852
0,22.1,Death,5,17105914
0,22.1,Hypokalaemia,1,17105920
1,22.1,Diarrhoea,6,17105920
2,22.1,Hypertension,6,17105920
3,22.1,Colitis ulcerative,2,17105920
0,22.1,Product prescribing error,6,17105939
1,22.1,Death,5,17105939
2,22.1,Abdominal distension,6,17105939
0,22.1,Ejection fraction decreased,1,17105982
1,22.1,Left ventricular dysfunction,1,17105982
0,22.1,Speech disorder,3,17106022
1,22.1,Asthenia,3,17106022
2,22.1,Gait inability,3,17106022
3,22.1,Metastases to bone,6,17106022
4,22.1,Pneumonia,6,17106022
5,22.1,Mobility decreased,3,17106022
0,22.1,Premature delivery,6,17106045
1,22.1,Foetal hypokinesia,6,17106045
2,22.1,Foetal exposure during pregnancy,6,17106045
0,22.1,Head injury,6,17106070
1,22.1,Death,5,17106070
2,22.1,Fall,6,17106070
0,22.1,Seizure,6,17106073
1,22.1,Nausea,6,17106073
2,22.1,Vomiting,6,17106073
3,22.1,Syncope,6,17106073
4,22.1,Heart rate decreased,1,17106073
5,22.1,Hypotension,1,17106073
0,22.1,Haematuria,6,17106094
1,22.1,Proteinuria,6,17106094
0,22.1,Renal impairment,6,17106123
0,22.1,Chronic myeloid leukaemia,6,17106127
0,22.1,Anaemia,6,17106137
1,22.1,Haematotoxicity,6,17106137
0,22.1,Platelet count decreased,2,17106147
1,22.1,Haemoglobin decreased,3,17106147
2,22.1,Blood potassium decreased,1,17106147
3,22.1,Fatigue,3,17106147
4,22.1,Product dose omission,6,17106147
5,22.1,Carbohydrate antigen 125 increased,3,17106147
6,22.1,Bone marrow failure,6,17106147
7,22.1,Blood magnesium decreased,1,17106147
8,22.1,Pruritus,6,17106147
9,22.1,Taste disorder,2,17106147
10,22.1,Nausea,3,17106147
0,22.1,Meningioma,6,17106169
1,22.1,Off label use,6,17106169
2,22.1,Rash,6,17106169
0,22.1,Proteinuria,2,17106250
1,22.1,Cardiac failure,6,17106250
0,22.1,Product use in unapproved indication,6,17106252
1,22.1,Disease progression,6,17106252
0,22.1,Skin toxicity,1,17106291
1,22.1,Neutropenia,1,17106291
0,22.1,Colitis,6,17106292
0,22.1,Myositis,3,17106322
1,22.1,Hypertension,1,17106322
2,22.1,Myocarditis,5,17106322
0,22.1,Death,5,17106338
0,22.1,Dyspnoea,6,17106341
1,22.1,Respiratory failure,6,17106341
2,22.1,Malignant neoplasm progression,6,17106341
3,22.1,Metastases to liver,6,17106341
0,22.1,Pneumonitis,6,17106342
1,22.1,Death,5,17106342
2,22.1,Pulmonary embolism,5,17106342
3,22.1,Therapeutic response decreased,6,17106342
0,22.1,Product use in unapproved indication,6,17106358
1,22.1,Vomiting,3,17106358
2,22.1,Malaise,3,17106358
0,22.1,Rash,3,17106362
1,22.1,Thrombosis,3,17106362
2,22.1,Drug ineffective,3,17106362
0,22.1,Cerebral infarction,2,17106369
0,22.1,Hair disorder,3,17106400
1,22.1,Hair texture abnormal,3,17106400
2,22.1,Madarosis,3,17106400
3,22.1,Alopecia,3,17106400
4,22.1,Hair colour changes,3,17106400
0,22.1,Death,5,17106426
0,22.1,Neoplasm malignant,5,17106453
0,22.1,Alopecia,3,17106471
1,22.1,Hair disorder,3,17106471
2,22.1,Hair colour changes,3,17106471
3,22.1,Hair texture abnormal,3,17106471
0,22.1,Renal disorder,6,17106474
0,22.1,Neoplasm progression,6,17106491
0,22.1,Metastases to bone,6,17106504
1,22.1,Metastases to central nervous system,6,17106504
2,22.1,Malignant neoplasm progression,6,17106504
0,22.1,Off label use,6,17106507
1,22.1,Product use in unapproved indication,6,17106507
2,22.1,Pain,3,17106507
0,22.1,Neoplasm progression,6,17106513
0,22.1,Death,5,17106526
0,22.1,Death,5,17106527
0,22.1,Pneumothorax,3,17106534
0,22.1,Hair colour changes,3,17106542
1,22.1,Alopecia,3,17106542
2,22.1,Hair disorder,3,17106542
3,22.1,Madarosis,3,17106542
4,22.1,Hair texture abnormal,3,17106542
0,22.1,Hair texture abnormal,3,17106562
1,22.1,Hair colour changes,3,17106562
2,22.1,Alopecia,3,17106562
3,22.1,Hair disorder,3,17106562
4,22.1,Madarosis,3,17106562
0,22.1,Hair colour changes,3,17106565
1,22.1,Hair disorder,3,17106565
2,22.1,Alopecia,3,17106565
3,22.1,Hair texture abnormal,3,17106565
0,22.1,Fall,6,17106569
0,22.1,Hair colour changes,3,17106575
1,22.1,Alopecia,3,17106575
2,22.1,Madarosis,3,17106575
3,22.1,Hair texture abnormal,3,17106575
4,22.1,Hair disorder,3,17106575
0,22.1,Disease progression,5,17106580
1,22.1,Intestinal obstruction,5,17106580
0,22.1,Mass,6,17106613
0,22.1,Neurotoxicity,4,17106614
1,22.1,Hypoacusis,4,17106614
2,22.1,Aplasia,4,17106614
0,22.1,Arrhythmia,6,17106629
1,22.1,Myocarditis,6,17106629
2,22.1,Death,5,17106629
0,22.1,Neurotoxicity,6,17106674
1,22.1,Haematotoxicity,6,17106674
0,22.1,Liver injury,,17106688
1,22.1,Oedema peripheral,2,17106688
2,22.1,Gastrointestinal haemorrhage,2,17106688
3,22.1,Asthma,2,17106688
4,22.1,Blood loss anaemia,2,17106688
5,22.1,Asthenia,2,17106688
6,22.1,Off label use,,17106688
7,22.1,Haematemesis,2,17106688
8,22.1,Cough,2,17106688
9,22.1,Pyrexia,2,17106688
10,22.1,Transaminases increased,,17106688
11,22.1,Dyspnoea,2,17106688
12,22.1,Pulmonary hilum mass,2,17106688
13,22.1,Blood potassium decreased,2,17106688
14,22.1,Suffocation feeling,2,17106688
15,22.1,General physical health deterioration,2,17106688
0,22.1,Necrotising retinitis,3,17106725
1,22.1,Retinal detachment,4,17106725
0,22.1,Mood swings,3,17106757
0,22.1,Death,5,17106796
0,22.1,Intentional product use issue,6,17106844
1,22.1,Off label use,6,17106844
2,22.1,Appendix cancer,5,17106844
0,22.1,Acute kidney injury,6,17106860
1,22.1,Diabetic ketoacidotic hyperglycaemic coma,6,17106860
2,22.1,Thrombocytopenia,6,17106860
3,22.1,Malignant neoplasm progression,6,17106860
4,22.1,Diabetes mellitus,6,17106860
0,22.1,Abdominal pain upper,6,17106866
1,22.1,Diarrhoea,6,17106866
2,22.1,Product dose omission,6,17106866
3,22.1,Platelet count decreased,1,17106866
4,22.1,Infection,6,17106866
0,22.1,Cerebral haemorrhage,6,17106878
0,22.1,Sepsis,1,17106882
1,22.1,Colonic fistula,1,17106882
0,22.1,Platelet count decreased,2,17106884
1,22.1,Interstitial lung disease,5,17106884
2,22.1,Malignant neoplasm progression,6,17106884
3,22.1,Pneumothorax,3,17106884
0,22.1,Imaging procedure abnormal,6,17106886
1,22.1,Pyrexia,6,17106886
2,22.1,Cough,6,17106886
3,22.1,Interstitial lung disease,1,17106886
0,22.1,Hepatic function abnormal,1,17106890
1,22.1,Rash,1,17106890
0,22.1,Dyspepsia,1,17106891
1,22.1,Drug ineffective,6,17106891
2,22.1,Metastases to spine,6,17106891
3,22.1,Malignant neoplasm progression,3,17106891
4,22.1,Flatulence,1,17106891
5,22.1,Abdominal discomfort,1,17106891
0,22.1,Depression,6,17106927
1,22.1,Alopecia,3,17106927
2,22.1,Hair texture abnormal,3,17106927
3,22.1,Madarosis,3,17106927
4,22.1,Hair disorder,3,17106927
5,22.1,Hair colour changes,3,17106927
6,22.1,Anxiety,6,17106927
0,22.1,Alopecia,3,17106938
1,22.1,Hair texture abnormal,3,17106938
2,22.1,Hair colour changes,3,17106938
3,22.1,Hair disorder,3,17106938
0,22.1,Osteonecrosis of jaw,6,17106940
1,22.1,Jaw fistula,6,17106940
0,22.1,Hair colour changes,3,17106942
1,22.1,Hair disorder,3,17106942
2,22.1,Madarosis,3,17106942
3,22.1,Alopecia,3,17106942
4,22.1,Hair texture abnormal,3,17106942
0,22.1,Alopecia,3,17106953
0,22.1,Hair disorder,3,17106956
1,22.1,Hair texture abnormal,3,17106956
2,22.1,Alopecia,3,17106956
3,22.1,Hair colour changes,3,17106956
4,22.1,Madarosis,3,17106956
5,22.1,Depression,6,17106956
0,22.1,Periprosthetic fracture,1,17106968
1,22.1,Cognitive disorder,3,17106968
0,22.1,Madarosis,3,17106969
1,22.1,Hair colour changes,6,17106969
2,22.1,Alopecia,3,17106969
3,22.1,Hair disorder,6,17106969
4,22.1,Hair texture abnormal,6,17106969
0,22.1,Neoplasm progression,6,17106972
0,22.1,Nocturia,3,17106973
1,22.1,Musculoskeletal discomfort,6,17106973
2,22.1,Skin exfoliation,6,17106973
3,22.1,Oral mucosal blistering,6,17106973
4,22.1,Stress,6,17106973
0,22.1,Madarosis,3,17106975
1,22.1,Hair texture abnormal,3,17106975
2,22.1,Alopecia,3,17106975
3,22.1,Hair disorder,3,17106975
4,22.1,Hair colour changes,3,17106975
0,22.1,Hair colour changes,3,17106984
1,22.1,Hair disorder,3,17106984
2,22.1,Alopecia,3,17106984
3,22.1,Hair texture abnormal,3,17106984
0,22.1,Hypersomnia,6,17106985
1,22.1,Dehydration,6,17106985
2,22.1,Dysphonia,6,17106985
3,22.1,Vomiting,6,17106985
4,22.1,Asthenia,2,17106985
5,22.1,Hypertension,6,17106985
6,22.1,Atrial fibrillation,6,17106985
7,22.1,Mood altered,6,17106985
0,22.1,Hair colour changes,3,17106994
1,22.1,Hair texture abnormal,3,17106994
2,22.1,Madarosis,1,17106994
3,22.1,Anxiety,6,17106994
4,22.1,Alopecia,3,17106994
5,22.1,Hair disorder,3,17106994
0,22.1,Fatigue,1,17107013
0,22.1,Acute febrile neutrophilic dermatosis,2,17107056
0,22.1,Death,5,17107097
1,22.1,Product use in unapproved indication,6,17107097
2,22.1,Back pain,6,17107097
3,22.1,Mobility decreased,6,17107097
0,22.1,Malignant neoplasm progression,6,17107125
0,22.1,Radiation pneumonitis,6,17107143
1,22.1,Pneumonitis,5,17107143
2,22.1,Pneumocystis jirovecii pneumonia,6,17107143
0,22.1,Disease progression,6,17107164
1,22.1,Drug ineffective,6,17107164
2,22.1,Recurrent cancer,6,17107164
3,22.1,Anaemia,6,17107164
0,22.1,Intentional product misuse,6,17107180
1,22.1,Drug ineffective,6,17107180
2,22.1,Recurrent cancer,6,17107180
3,22.1,Disease progression,6,17107180
0,22.1,Nausea,6,17107181
1,22.1,Vomiting,6,17107181
2,22.1,Product use in unapproved indication,6,17107181
0,22.1,Feeling hot,3,17107182
1,22.1,Hot flush,3,17107182
2,22.1,Constipation,3,17107182
3,22.1,Hallucination,6,17107182
4,22.1,Decreased appetite,3,17107182
5,22.1,Nausea,2,17107182
6,22.1,Fatigue,3,17107182
7,22.1,Dyspnoea,6,17107182
8,22.1,Sinus disorder,2,17107182
9,22.1,Insomnia,3,17107182
0,22.1,Recurrent cancer,6,17107184
1,22.1,Disease progression,6,17107184
2,22.1,Drug tolerance,6,17107184
0,22.1,Recurrent cancer,6,17107185
1,22.1,Drug ineffective,6,17107185
2,22.1,Disease progression,6,17107185
0,22.1,Disease progression,6,17107186
1,22.1,Intentional product misuse,6,17107186
2,22.1,Recurrent cancer,6,17107186
0,22.1,Recurrent cancer,6,17107189
1,22.1,Disease progression,6,17107189
2,22.1,Haematotoxicity,6,17107189
3,22.1,Drug ineffective,6,17107189
0,22.1,Disease progression,6,17107196
1,22.1,Recurrent cancer,6,17107196
0,22.1,Decreased appetite,6,17107197
1,22.1,Supraventricular tachycardia,1,17107197
2,22.1,Atrial fibrillation,1,17107197
3,22.1,Hypomagnesaemia,6,17107197
4,22.1,Palpitations,6,17107197
5,22.1,Adverse drug reaction,6,17107197
6,22.1,Dizziness,6,17107197
7,22.1,Dyspnoea,6,17107197
8,22.1,Nausea,3,17107197
9,22.1,Tremor,3,17107197
10,22.1,Fatigue,3,17107197
11,22.1,Heart rate irregular,6,17107197
12,22.1,Benign abdominal neoplasm,6,17107197
13,22.1,Drug intolerance,3,17107197
0,22.1,Blood disorder,1,17107198
1,22.1,Anaemia,6,17107198
0,22.1,Urinary tract obstruction,6,17107199
0,22.1,Breast cancer,6,17107202
0,22.1,Sepsis,5,17107203
0,22.1,Syncope,1,17107218
0,22.1,Acute leukaemia,2,17107250
1,22.1,Pain in extremity,6,17107250
0,22.1,Inappropriate schedule of product administration,6,17107256
1,22.1,Bone marrow failure,6,17107256
0,22.1,Bone marrow failure,1,17107260
0,22.1,Maternal exposure during pregnancy,1,17107284
1,22.1,Anaemia,6,17107284
2,22.1,Vomiting,6,17107284
3,22.1,Premature delivery,6,17107284
4,22.1,Menopause,6,17107284
5,22.1,Nausea,6,17107284
0,22.1,Death,5,17107287
0,22.1,Dehydration,2,17107312
0,22.1,Pulmonary oedema,6,17107315
1,22.1,Ventricular enlargement,6,17107315
2,22.1,Lymphangiosis carcinomatosa,6,17107315
3,22.1,Dyspnoea,6,17107315
4,22.1,Atrial fibrillation,6,17107315
5,22.1,Hypoxia,6,17107315
6,22.1,Cardiac failure,6,17107315
0,22.1,Drug ineffective,2,17107326
0,22.1,Microembolism,6,17107330
0,22.1,Memory impairment,3,17107369
1,22.1,Language disorder,3,17107369
2,22.1,Cognitive disorder,3,17107369
0,22.1,Feeling cold,1,17107370
1,22.1,Throat irritation,1,17107370
2,22.1,Rash,1,17107370
0,22.1,Toxic skin eruption,6,17107396
1,22.1,Pyrexia,1,17107396
0,22.1,Renal haemorrhage,3,17107405
1,22.1,Renal neoplasm,3,17107405
2,22.1,Transplantation complication,3,17107405
0,22.1,Haemolytic anaemia,3,17107442
1,22.1,Cough,3,17107442
2,22.1,Thrombocytopenia,3,17107442
3,22.1,Dyspnoea,3,17107442
4,22.1,Pancytopenia,1,17107442
0,22.1,Hypersensitivity,6,17107465
1,22.1,Pain,2,17107465
2,22.1,Pneumonia,6,17107465
3,22.1,Chills,6,17107465
4,22.1,Axillary pain,6,17107465
5,22.1,Nasopharyngitis,6,17107465
6,22.1,Pyrexia,6,17107465
7,22.1,Dyspnoea,2,17107465
8,22.1,Fatigue,6,17107465
9,22.1,Eructation,6,17107465
10,22.1,Dizziness,3,17107465
0,22.1,Death,5,17107544
0,22.1,Limb discomfort,3,17107549
1,22.1,Musculoskeletal discomfort,3,17107549
2,22.1,Diarrhoea,3,17107549
0,22.1,Malignant neoplasm progression,6,17107574
1,22.1,Diarrhoea,1,17107574
2,22.1,Stomatitis,1,17107574
3,22.1,Intentional product use issue,6,17107574
4,22.1,Asthenia,1,17107574
5,22.1,Transaminases increased,1,17107574
0,22.1,Pain in extremity,1,17107644
1,22.1,Thrombosis,6,17107644
2,22.1,Supraventricular tachycardia,6,17107644
3,22.1,Myocardial infarction,6,17107644
0,22.1,Hypokalaemia,2,17107659
1,22.1,Hypocalcaemia,2,17107659
2,22.1,Diarrhoea,3,17107659
3,22.1,Hypomagnesaemia,2,17107659
0,22.1,Death,5,17107664
0,22.1,Haemoglobin decreased,6,17107670
1,22.1,Troponin I increased,2,17107670
0,22.1,Myasthenia gravis,2,17107711
1,22.1,Neuropathy peripheral,2,17107711
0,22.1,Drug ineffective,6,17107739
0,22.1,Hallucination,5,17107754
1,22.1,Confusional state,5,17107754
0,22.1,Death,5,17107814
0,22.1,Death,5,17107819
0,22.1,Device leakage,,17107893
1,22.1,Syringe issue,,17107893
2,22.1,Intercepted product administration error,,17107893
0,22.1,Nasopharyngitis,6,17107946
0,22.1,Pneumonia,1,17107989
0,22.1,Umbilical hernia,6,17108008
0,22.1,Muscular weakness,3,17108039
1,22.1,Muscular weakness,3,17108039
0,22.1,Rash,1,17108084
0,22.1,Death,5,17108116
0,22.1,Hot flush,3,17108156
1,22.1,Loss of libido,3,17108156
2,22.1,Burning sensation,3,17108156
0,22.1,Febrile neutropenia,5,17108241
0,22.1,Respiratory failure,5,17108243
1,22.1,Septic shock,5,17108243
0,22.1,Colorectal cancer,3,17108304
0,22.1,Indifference,2,17108306
1,22.1,Delirium,2,17108306
2,22.1,Disorientation,2,17108306
0,22.1,Pneumonia,5,17108383
1,22.1,Septic shock,5,17108383
2,22.1,Infection,6,17108383
0,22.1,Chills,1,17108395
1,22.1,Pruritus,1,17108395
2,22.1,Infusion related reaction,1,17108395
3,22.1,Chest discomfort,1,17108395
4,22.1,Hypertension,1,17108395
5,22.1,Laryngospasm,1,17108395
6,22.1,Flushing,1,17108395
0,22.1,Respiratory failure,5,17108398
1,22.1,Diarrhoea,5,17108398
0,22.1,Metastases to liver,6,17108549
1,22.1,Polyneuropathy,6,17108549
2,22.1,Leukopenia,6,17108549
3,22.1,Lymphadenopathy,6,17108549
4,22.1,Rash pustular,6,17108549
5,22.1,Neutropenia,6,17108549
0,22.1,Vena cava thrombosis,1,17108569
0,22.1,Disease progression,6,17108620
1,22.1,Toxicity to various agents,6,17108620
2,22.1,Recurrent cancer,6,17108620
3,22.1,Drug tolerance,6,17108620
0,22.1,Recurrent cancer,6,17108622
1,22.1,Disease progression,6,17108622
2,22.1,Drug ineffective,6,17108622
3,22.1,Thrombocytopenia,6,17108622
0,22.1,Hypersensitivity,1,17108627
1,22.1,Back pain,1,17108627
0,22.1,Anaemia,3,17108632
1,22.1,Thrombocytopenia,3,17108632
0,22.1,Disease progression,6,17108654
1,22.1,Recurrent cancer,6,17108654
0,22.1,Recurrent cancer,6,17108655
1,22.1,Neutropenia,6,17108655
0,22.1,Dyspnoea,5,17108657
1,22.1,Urosepsis,2,17108657
0,22.1,Skin ulcer,6,17108681
1,22.1,Fatigue,6,17108681
2,22.1,Diarrhoea,6,17108681
3,22.1,Skin erosion,6,17108681
4,22.1,Chest pain,6,17108681
5,22.1,Blood pressure increased,6,17108681
6,22.1,Chest discomfort,6,17108681
7,22.1,Muscle spasms,6,17108681
8,22.1,Gastric ulcer haemorrhage,1,17108681
9,22.1,Dizziness,6,17108681
0,22.1,Hyperglycaemia,1,17108692
0,22.1,Anaemia,6,17108697
1,22.1,Thrombocytopenia,6,17108697
2,22.1,Off label use,6,17108697
3,22.1,Product use in unapproved indication,6,17108697
0,22.1,Drug interaction,5,17108746
1,22.1,Neoplasm progression,5,17108746
2,22.1,Polyneuropathy,5,17108746
0,22.1,Anaemia,3,17108757
1,22.1,Malignant neoplasm progression,5,17108757
2,22.1,Platelet count decreased,3,17108757
3,22.1,Rash,2,17108757
0,22.1,Paraesthesia oral,1,17108763
1,22.1,Feeling hot,1,17108763
2,22.1,Blood pressure increased,1,17108763
3,22.1,Asthenia,1,17108763
4,22.1,Dysarthria,1,17108763
0,22.1,Fall,6,17108789
1,22.1,Hip fracture,2,17108789
0,22.1,Peripheral ischaemia,1,17108803
1,22.1,Drug interaction,6,17108803
0,22.1,Malaise,3,17108839
1,22.1,Therapy non-responder,6,17108839
2,22.1,Prostate cancer,6,17108839
3,22.1,Prostatic specific antigen increased,3,17108839
0,22.1,Foetal hypokinesia,6,17108841
1,22.1,Premature delivery,6,17108841
2,22.1,Maternal exposure during pregnancy,6,17108841
0,22.1,Cerebrovascular accident,6,17108848
1,22.1,Rash,6,17108848
2,22.1,Infection,6,17108848
0,22.1,Systemic lupus erythematosus,2,17108863
0,22.1,Hot flush,3,17108911
0,22.1,Febrile neutropenia,1,17108926
1,22.1,Diarrhoea,1,17108926
2,22.1,Enteritis,1,17108926
3,22.1,Colitis,3,17108926
0,22.1,Hyperglycaemia,6,17108927
1,22.1,Blood creatinine increased,6,17108927
0,22.1,Treatment failure,6,17108944
1,22.1,Renal failure,6,17108944
2,22.1,Drug ineffective,6,17108944
3,22.1,Ureteric cancer,6,17108944
0,22.1,Colitis,1,17108989
0,22.1,Fall,2,17108995
1,22.1,Nausea,2,17108995
2,22.1,Vomiting,2,17108995
0,22.1,Dehydration,6,17109065
0,22.1,Asthenia,2,17109068
1,22.1,Abdominal pain,2,17109068
2,22.1,Nausea,2,17109068
3,22.1,Decreased appetite,2,17109068
4,22.1,Vomiting,2,17109068
5,22.1,Fatigue,2,17109068
0,22.1,Erysipelas,1,17109088
0,22.1,Metastases to peritoneum,5,17109118
1,22.1,Anaemia,1,17109118
0,22.1,Diarrhoea,1,17109145
1,22.1,Malaise,1,17109145
2,22.1,Hypertension,1,17109145
3,22.1,Hypotension,1,17109145
4,22.1,Erythema,1,17109145
0,22.1,Muscular weakness,3,17109152
0,22.1,Polyneuropathy,3,17109216
1,22.1,Off label use,6,17109216
0,22.1,Off label use,6,17109217
1,22.1,Pulmonary embolism,3,17109217
0,22.1,Sepsis,1,17109248
0,22.1,Death,5,17109277
0,22.1,Myocardial infarction,1,17109283
0,22.1,Ileus,1,17109289
0,22.1,Malignant neoplasm progression,6,17109292
0,22.1,Interstitial lung disease,3,17109333
0,22.1,Tachycardia,1,17109341
1,22.1,Chest pain,1,17109341
2,22.1,Dyspnoea,1,17109341
3,22.1,Flushing,1,17109341
0,22.1,Gastrointestinal haemorrhage,1,17109348
1,22.1,Urinary retention,1,17109348
0,22.1,Myocardial ischaemia,6,17109356
0,22.1,Intestinal perforation,1,17109407
0,22.1,Thrombocytopenia,1,17109409
1,22.1,Anaemia,1,17109409
0,22.1,Neuropathy peripheral,3,17109420
1,22.1,Oral mucosal erythema,6,17109420
2,22.1,Memory impairment,3,17109420
3,22.1,Myalgia,3,17109420
4,22.1,Oral pain,6,17109420
5,22.1,Loose tooth,3,17109420
6,22.1,Arthralgia,3,17109420
7,22.1,Oral fungal infection,6,17109420
8,22.1,Fatigue,3,17109420
9,22.1,Paraesthesia,6,17109420
10,22.1,Disturbance in attention,6,17109420
11,22.1,Hypoaesthesia,3,17109420
0,22.1,Nausea,1,17109446
1,22.1,Metastasis,6,17109446
2,22.1,Depressed mood,1,17109446
3,22.1,Drug ineffective,6,17109446
4,22.1,Prostatic specific antigen increased,6,17109446
5,22.1,Fatigue,2,17109446
0,22.1,Prostatic specific antigen decreased,6,17109455
1,22.1,Product use in unapproved indication,6,17109455
2,22.1,Drug effective for unapproved indication,6,17109455
0,22.1,Myeloproliferative neoplasm,6,17109477
0,22.1,Feeling abnormal,6,17109520
1,22.1,Tachycardia,1,17109520
2,22.1,Cardiac arrest,2,17109520
3,22.1,Dyspnoea,1,17109520
4,22.1,Arteriospasm coronary,6,17109520
5,22.1,Chest pain,1,17109520
6,22.1,Lethargy,1,17109520
7,22.1,Arrhythmia,6,17109520
0,22.1,Osteonecrosis of jaw,3,17109702
1,22.1,Tooth extraction,6,17109702
0,22.1,Infarction,5,17109719
0,22.1,Rash,1,17109810
1,22.1,Abdominal distension,1,17109810
2,22.1,Rash pruritic,1,17109810
3,22.1,Erythema,1,17109810
4,22.1,Chills,1,17109810
0,22.1,Intentional product use issue,6,17109827
1,22.1,Death,5,17109827
0,22.1,Anaphylactic reaction,4,17109836
0,22.1,Abdominal pain upper,2,17109900
1,22.1,Diarrhoea,6,17109900
2,22.1,Gastritis,6,17109900
0,22.1,Arthralgia,2,17109923
1,22.1,Joint swelling,2,17109923
2,22.1,Alopecia,2,17109923
0,22.1,Purpura,6,17109927
1,22.1,Facial paralysis,6,17109927
0,22.1,Rectal haemorrhage,1,17109966
1,22.1,Application site inflammation,2,17109966
2,22.1,Skin burning sensation,6,17109966
3,22.1,Platelet disorder,6,17109966
4,22.1,Anisocytosis,6,17109966
5,22.1,Mean cell haemoglobin increased,6,17109966
6,22.1,Lymphocyte count increased,6,17109966
7,22.1,Constipation,1,17109966
8,22.1,Blood test abnormal,6,17109966
9,22.1,Gastric disorder,6,17109966
10,22.1,Poikilocytosis,6,17109966
11,22.1,Globulins decreased,3,17109966
12,22.1,Cough,3,17109966
13,22.1,Drug ineffective,6,17109966
14,22.1,Platelet count decreased,3,17109966
15,22.1,Monocyte count increased,6,17109966
16,22.1,Neutrophil count decreased,6,17109966
17,22.1,Application site pruritus,2,17109966
18,22.1,Hypermetabolism,6,17109966
19,22.1,Depressed mood,6,17109966
20,22.1,Polyp,1,17109966
21,22.1,Blood cholesterol increased,6,17109966
22,22.1,Red blood cell elliptocytes present,6,17109966
23,22.1,Fatigue,6,17109966
24,22.1,Red blood cell count decreased,6,17109966
25,22.1,Pruritus,6,17109966
26,22.1,Nasopharyngitis,6,17109966
27,22.1,Underdose,6,17109966
28,22.1,Leukopenia,6,17109966
29,22.1,Pulmonary mass,6,17109966
30,22.1,Red cell distribution width increased,6,17109966
31,22.1,Visual impairment,3,17109966
0,22.1,Cutaneous lupus erythematosus,2,17109973
0,22.1,Lymphocytosis,6,17109974
1,22.1,Constipation,6,17109974
2,22.1,Neutropenia,6,17109974
3,22.1,Mucosal dryness,6,17109974
4,22.1,Fatigue,6,17109974
5,22.1,Musculoskeletal discomfort,6,17109974
6,22.1,Androgenetic alopecia,6,17109974
7,22.1,Joint stiffness,6,17109974
0,22.1,Death,5,17110021
0,22.1,Off label use,6,17110077
0,22.1,Tumour pseudoprogression,2,17110110
0,22.1,Product quality issue,3,17110183
1,22.1,Off label use,3,17110183
2,22.1,Product adhesion issue,3,17110183
0,22.1,Visual impairment,1,17110213
1,22.1,Eating disorder,2,17110213
2,22.1,Aphasia,2,17110213
3,22.1,Altered state of consciousness,2,17110213
4,22.1,Tremor,1,17110213
5,22.1,Dysphoria,2,17110213
6,22.1,Headache,6,17110213
0,22.1,Cardiac failure acute,2,17110223
1,22.1,Oedema peripheral,2,17110223
2,22.1,Acute pulmonary oedema,1,17110223
0,22.1,Hepatobiliary disease,2,17110231
0,22.1,Malaise,6,17110238
1,22.1,Rash,6,17110238
2,22.1,Drug hypersensitivity,6,17110238
0,22.1,Pyrexia,1,17110322
0,22.1,Drug ineffective,6,17110324
1,22.1,Nausea,3,17110324
2,22.1,Vomiting,3,17110324
3,22.1,Ascites,6,17110324
4,22.1,Diarrhoea,3,17110324
5,22.1,Malaise,3,17110324
6,22.1,Musculoskeletal chest pain,6,17110324
7,22.1,Abdominal pain,3,17110324
0,22.1,Hypotension,1,17110349
1,22.1,Oxygen saturation decreased,1,17110349
2,22.1,Agitation,1,17110349
3,22.1,Tremor,1,17110349
0,22.1,Aphasia,6,17110352
1,22.1,General physical health deterioration,6,17110352
2,22.1,Gait disturbance,6,17110352
0,22.1,Hyperbilirubinaemia,1,17110353
1,22.1,Neoplasm progression,6,17110353
0,22.1,Malignant neoplasm progression,6,17110369
1,22.1,Interstitial lung disease,6,17110369
0,22.1,Death,5,17110419
0,22.1,Interstitial lung disease,5,17110447
0,22.1,Dyspnoea,1,17110453
1,22.1,Glaucoma,6,17110453
2,22.1,Blindness,6,17110453
3,22.1,Blood pressure decreased,1,17110453
0,22.1,Ileal perforation,4,17110467
0,22.1,Death,5,17110483
0,22.1,Nephrolithiasis,6,17110535
0,22.1,Meningitis listeria,5,17110542
0,22.1,Malaise,3,17110545
1,22.1,Stomatitis,3,17110545
0,22.1,Intestinal ischaemia,1,17110548
1,22.1,Gastrointestinal necrosis,1,17110548
2,22.1,Anaphylactic shock,1,17110548
0,22.1,Malignant neoplasm progression,6,17110549
1,22.1,Confusional state,6,17110549
2,22.1,Dyspnoea,6,17110549
0,22.1,Erythema multiforme,1,17110552
1,22.1,Neutropenia,1,17110552
2,22.1,Faeces soft,6,17110552
3,22.1,White blood cell count decreased,1,17110552
0,22.1,Phlebitis,6,17110555
1,22.1,Pulmonary embolism,6,17110555
0,22.1,Rash,6,17110556
1,22.1,Urticaria,6,17110556
2,22.1,Swollen tongue,6,17110556
3,22.1,Diarrhoea,6,17110556
4,22.1,Drug hypersensitivity,6,17110556
5,22.1,Vomiting,6,17110556
6,22.1,Eye swelling,6,17110556
7,22.1,Dehydration,6,17110556
0,22.1,Weight decreased,6,17110557
1,22.1,Dysphagia,6,17110557
2,22.1,Diarrhoea,6,17110557
3,22.1,Dehydration,6,17110557
4,22.1,Feeding disorder,6,17110557
0,22.1,Hypotension,6,17110561
1,22.1,Loss of consciousness,6,17110561
2,22.1,Diarrhoea,6,17110561
0,22.1,Hair texture abnormal,3,17110581
1,22.1,Alopecia,3,17110581
2,22.1,Hair disorder,3,17110581
3,22.1,Depression,6,17110581
4,22.1,Hair colour changes,3,17110581
5,22.1,Madarosis,3,17110581
0,22.1,Hair colour changes,3,17110583
1,22.1,Alopecia,3,17110583
2,22.1,Hair disorder,3,17110583
3,22.1,Madarosis,3,17110583
4,22.1,Hair texture abnormal,3,17110583
0,22.1,Thrombocytopenia,1,17110590
1,22.1,Lymphopenia,1,17110590
0,22.1,Neoplasm progression,6,17110610
0,22.1,Skin burning sensation,6,17110638
1,22.1,Pruritus,6,17110638
2,22.1,Nausea,6,17110638
3,22.1,Paraesthesia,6,17110638
0,22.1,Injection site haemorrhage,1,17110665
1,22.1,Nausea,1,17110665
2,22.1,Pulmonary embolism,1,17110665
3,22.1,Abdominal pain,3,17110665
4,22.1,Vomiting,1,17110665
5,22.1,Decreased appetite,3,17110665
0,22.1,Diarrhoea,6,17110672
1,22.1,Cough,6,17110672
2,22.1,Rhinorrhoea,6,17110672
3,22.1,Nasal congestion,6,17110672
4,22.1,Fatigue,6,17110672
0,22.1,Leukopenia,1,17110679
1,22.1,Off label use,6,17110679
2,22.1,Neutropenia,1,17110679
0,22.1,Faeces soft,6,17110685
1,22.1,Dizziness,6,17110685
2,22.1,Asthenia,6,17110685
3,22.1,Diarrhoea,6,17110685
4,22.1,Abdominal discomfort,6,17110685
5,22.1,Fatigue,6,17110685
0,22.1,Nausea,6,17110696
1,22.1,Chills,6,17110696
2,22.1,Fatigue,6,17110696
0,22.1,Off label use,6,17110701
1,22.1,Neoplasm progression,6,17110701
2,22.1,Product use in unapproved indication,6,17110701
0,22.1,Nausea,6,17110712
1,22.1,Musculoskeletal chest pain,6,17110712
0,22.1,Hypoacusis,6,17110719
0,22.1,Blood count abnormal,6,17110726
1,22.1,Neutropenia,2,17110726
2,22.1,White blood cell count decreased,6,17110726
3,22.1,Diarrhoea,6,17110726
0,22.1,Blood count abnormal,6,17110728
0,22.1,Malignant neoplasm progression,6,17110781
0,22.1,Cerebrovascular accident,2,17110803
0,22.1,Product packaging issue,6,17110830
1,22.1,Product dose omission,6,17110830
2,22.1,Adrenal insufficiency,2,17110830
0,22.1,Dyspnoea exertional,3,17110841
1,22.1,Dyspnoea,1,17110841
0,22.1,Bone marrow failure,1,17110859
0,22.1,Drug-induced liver injury,2,17110863
0,22.1,Urinary tract infection,1,17110892
1,22.1,Malnutrition,1,17110892
0,22.1,Joint stiffness,3,17110938
1,22.1,Pain in extremity,3,17110938
2,22.1,Hypoaesthesia,3,17110938
3,22.1,Vulvovaginal dryness,3,17110938
4,22.1,Musculoskeletal stiffness,3,17110938
5,22.1,Arthralgia,3,17110938
0,22.1,Madarosis,3,17110956
1,22.1,Hair texture abnormal,6,17110956
2,22.1,Hair colour changes,6,17110956
3,22.1,Alopecia,3,17110956
4,22.1,Hair disorder,6,17110956
0,22.1,Alopecia,3,17110958
1,22.1,Hair disorder,3,17110958
2,22.1,Hair colour changes,3,17110958
3,22.1,Hair texture abnormal,3,17110958
4,22.1,Madarosis,3,17110958
0,22.1,Alopecia,3,17110963
1,22.1,Hair texture abnormal,3,17110963
2,22.1,Hair disorder,3,17110963
3,22.1,Madarosis,3,17110963
4,22.1,Hair colour changes,3,17110963
0,22.1,Neoplasm progression,6,17110980
0,22.1,Polyneuropathy,6,17110983
0,22.1,Hepatocellular injury,2,17110997
1,22.1,Cholestasis,2,17110997
0,22.1,Proctitis,2,17110999
1,22.1,Inappropriate schedule of product administration,6,17110999
0,22.1,General physical health deterioration,1,17111055
1,22.1,Large intestine perforation,4,17111055
0,22.1,Neoplasm progression,6,17111130
1,22.1,Fatigue,6,17111130
2,22.1,Bone marrow failure,6,17111130
3,22.1,Dyspnoea,6,17111130
0,22.1,Oral pain,6,17111133
1,22.1,Nausea,6,17111133
2,22.1,Fatigue,6,17111133
3,22.1,Leukopenia,6,17111133
4,22.1,Neutropenia,6,17111133
5,22.1,Bone marrow failure,6,17111133
6,22.1,Thrombocytopenia,6,17111133
7,22.1,Dysgeusia,6,17111133
8,22.1,Diarrhoea,6,17111133
0,22.1,Pyrexia,,17111156
0,22.1,Infection,,17111161
1,22.1,Chills,,17111161
2,22.1,Pyrexia,,17111161
3,22.1,Therapy cessation,,17111161
0,22.1,Pruritus,2,17111170
1,22.1,Dermatitis bullous,2,17111170
2,22.1,White blood cell count decreased,1,17111170
3,22.1,Vomiting,1,17111170
4,22.1,Aspartate aminotransferase increased,1,17111170
5,22.1,Neutrophil count decreased,1,17111170
6,22.1,Pyrexia,1,17111170
7,22.1,Alanine aminotransferase increased,1,17111170
0,22.1,Angina unstable,6,17111174
1,22.1,Acute myocardial infarction,6,17111174
0,22.1,Toxicity to various agents,1,17111231
0,22.1,Maternal exposure during pregnancy,6,17111245
1,22.1,Premature baby,6,17111245
0,22.1,Premature baby,1,17111269
1,22.1,Maternal exposure during pregnancy,1,17111269
0,22.1,Neutropenia,1,17111338
0,22.1,Haematotoxicity,6,17111380
1,22.1,Neurotoxicity,6,17111380
0,22.1,Dyspnoea,6,17111404
1,22.1,Urinary tract infection,6,17111404
2,22.1,Drug tolerance decreased,6,17111404
3,22.1,Asthenia,6,17111404
0,22.1,Pancytopenia,6,17111408
1,22.1,Asthenia,6,17111408
0,22.1,Oral herpes,3,17111412
0,22.1,Oral herpes,6,17111417
0,22.1,Surgery,,17111460
1,22.1,Therapy cessation,,17111460
0,22.1,Drug eruption,1,17111462
0,22.1,Osteonecrosis of jaw,1,17111476
0,22.1,Neutrophil count decreased,1,17111506
1,22.1,Ascites,2,17111506
2,22.1,Dry skin,3,17111506
3,22.1,White blood cell count decreased,6,17111506
4,22.1,Liver function test increased,3,17111506
5,22.1,Portal hypertension,6,17111506
6,22.1,Neutrophil count decreased,3,17111506
0,22.1,Interstitial lung disease,1,17111507
0,22.1,Death,5,17111514
0,22.1,Arrhythmia supraventricular,3,17111523
1,22.1,Cardiac failure,1,17111523
0,22.1,Back pain,6,17111542
1,22.1,Arrhythmia,6,17111542
2,22.1,Sense of oppression,6,17111542
3,22.1,Neurological symptom,6,17111542
4,22.1,Neurotoxicity,1,17111542
5,22.1,Aphasia,1,17111542
6,22.1,Dizziness,6,17111542
7,22.1,Nausea,6,17111542
8,22.1,Palpitations,6,17111542
9,22.1,Supraventricular extrasystoles,1,17111542
10,22.1,Loss of consciousness,6,17111542
11,22.1,Cardiotoxicity,1,17111542
0,22.1,Hypertriglyceridaemia,6,17111550
1,22.1,Gamma-glutamyltransferase increased,6,17111550
2,22.1,Alanine aminotransferase increased,6,17111550
3,22.1,Blood alkaline phosphatase increased,6,17111550
0,22.1,Hepatitis B,2,17111554
1,22.1,Anaemia,3,17111554
2,22.1,Pyrexia,1,17111554
3,22.1,Weight decreased,1,17111554
4,22.1,Decreased appetite,1,17111554
5,22.1,Abdominal infection,6,17111554
0,22.1,Neoplasm progression,6,17111617
1,22.1,Ileus,6,17111617
0,22.1,Subileus,1,17111634
1,22.1,Anastomotic complication,5,17111634
0,22.1,Death,,17111647
0,22.1,Abdominal pain upper,1,17111651
1,22.1,Pyrexia,1,17111651
2,22.1,Nausea,1,17111651
3,22.1,Chills,1,17111651
4,22.1,Malaise,6,17111651
5,22.1,Myalgia,1,17111651
6,22.1,Fatigue,6,17111651
0,22.1,Lung disorder,2,17111653
0,22.1,Death,5,17111668
0,22.1,Left ventricular dysfunction,2,17111677
1,22.1,Cardiac dysfunction,2,17111677
2,22.1,Congestive cardiomyopathy,2,17111677
3,22.1,Mitral valve incompetence,2,17111677
4,22.1,Coronary artery disease,2,17111677
5,22.1,Cardiac failure chronic,2,17111677
6,22.1,Bundle branch block left,2,17111677
0,22.1,Delirium,6,17111774
1,22.1,Malignant neoplasm progression,5,17111774
2,22.1,Gynaecomastia,6,17111774
3,22.1,Off label use,6,17111774
4,22.1,Interstitial lung disease,1,17111774
0,22.1,Lumbar vertebral fracture,,17111812
1,22.1,Urinary tract infection,,17111812
2,22.1,Blood urine present,,17111812
0,22.1,Tumour hyperprogression,1,17111903
0,22.1,Pneumonitis,6,17111919
0,22.1,Hip fracture,6,17111941
1,22.1,Pain in extremity,6,17111941
0,22.1,Ear infection,1,17111950
1,22.1,Eye swelling,6,17111950
2,22.1,Constipation,6,17111950
3,22.1,Diarrhoea,3,17111950
4,22.1,Pain,6,17111950
5,22.1,Nausea,3,17111950
6,22.1,Flushing,6,17111950
7,22.1,Dry mouth,3,17111950
8,22.1,Dizziness,3,17111950
9,22.1,Vomiting,6,17111950
0,22.1,Nausea,1,17111955
1,22.1,Pyrexia,1,17111955
2,22.1,Back pain,1,17111955
3,22.1,Vomiting,1,17111955
0,22.1,Aortic dissection,6,17111972
0,22.1,Asthenia,,17111974
0,22.1,Hospitalisation,,17111992
0,22.1,Death,5,17112010
0,22.1,Malignant neoplasm progression,6,17112034
1,22.1,Renal impairment,2,17112034
0,22.1,Malignant neoplasm progression,6,17112054
1,22.1,Diarrhoea,6,17112054
0,22.1,Death,5,17112056
0,22.1,Nausea,1,17112065
1,22.1,Blood creatinine increased,6,17112065
2,22.1,Platelet count decreased,1,17112065
3,22.1,Malignant neoplasm progression,6,17112065
4,22.1,Anaemia,1,17112065
5,22.1,Malaise,1,17112065
6,22.1,White blood cell count decreased,6,17112065
7,22.1,Fatigue,6,17112065
8,22.1,Metastases to peritoneum,6,17112065
0,22.1,Thrombophlebitis,1,17112080
1,22.1,Atrial fibrillation,1,17112080
0,22.1,Aspartate aminotransferase increased,2,17112098
1,22.1,Alanine aminotransferase increased,2,17112098
0,22.1,Haemoglobin decreased,6,17112112
1,22.1,Platelet count decreased,2,17112112
2,22.1,Weight decreased,6,17112112
3,22.1,Rash,6,17112112
4,22.1,Decreased appetite,3,17112112
5,22.1,White blood cell count decreased,2,17112112
6,22.1,Blister,6,17112112
7,22.1,Pyrexia,6,17112112
8,22.1,Cystitis,6,17112112
9,22.1,Carcinoembryonic antigen increased,6,17112112
10,22.1,Urethral prolapse,6,17112112
11,22.1,Fatigue,3,17112112
12,22.1,Urinary bladder haemorrhage,6,17112112
13,22.1,Neutrophil count decreased,6,17112112
14,22.1,Night sweats,1,17112112
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,17112124
1,22.1,Oesophagitis,1,17112124
2,22.1,Confusional state,1,17112124
3,22.1,Hyperthyroidism,1,17112124
4,22.1,Dehydration,1,17112124
5,22.1,Memory impairment,1,17112124
6,22.1,Decreased appetite,1,17112124
0,22.1,Cardiac failure,5,17112137
0,22.1,Mouth ulceration,6,17112147
1,22.1,Weight decreased,1,17112147
2,22.1,Feeling cold,1,17112147
3,22.1,Tooth loss,6,17112147
4,22.1,Somnolence,1,17112147
5,22.1,Joint swelling,1,17112147
6,22.1,Musculoskeletal stiffness,1,17112147
7,22.1,Decreased appetite,1,17112147
0,22.1,Fall,3,17112155
1,22.1,Pain,3,17112155
2,22.1,Diarrhoea,3,17112155
3,22.1,Myalgia,3,17112155
4,22.1,Weight increased,3,17112155
5,22.1,Hot flush,3,17112155
6,22.1,Wrist fracture,6,17112155
7,22.1,Gingival bleeding,1,17112155
8,22.1,Fatigue,3,17112155
9,22.1,Arthralgia,3,17112155
0,22.1,Infected seroma,3,17112179
0,22.1,Headache,6,17112200
1,22.1,Dry mouth,3,17112200
2,22.1,Productive cough,3,17112200
3,22.1,Arthralgia,3,17112200
4,22.1,Fatigue,6,17112200
5,22.1,Death,5,17112200
6,22.1,Pain,6,17112200
7,22.1,Product dose omission,6,17112200
0,22.1,Product availability issue,6,17112201
1,22.1,Blood magnesium decreased,6,17112201
2,22.1,Product dose omission,6,17112201
3,22.1,Pain in extremity,1,17112201
4,22.1,Haematochezia,1,17112201
5,22.1,Nausea,1,17112201
0,22.1,Stomatitis,,17112229
0,22.1,Abdominal pain,,17112239
1,22.1,Dysuria,,17112239
2,22.1,Rash,,17112239
3,22.1,Pruritus,,17112239
4,22.1,Burning sensation,,17112239
0,22.1,Product use in unapproved indication,6,17112246
1,22.1,Death,5,17112246
0,22.1,Oropharyngeal pain,6,17112248
1,22.1,Rash,6,17112248
2,22.1,Anaphylactic reaction,1,17112248
3,22.1,Pyrexia,6,17112248
0,22.1,Dermatitis,2,17112253
1,22.1,Erythema,2,17112253
2,22.1,Nodule,2,17112253
3,22.1,Pruritus,2,17112253
4,22.1,Papule,2,17112253
5,22.1,Eczema,2,17112253
6,22.1,Rash,2,17112253
7,22.1,Lichenification,2,17112253
0,22.1,Product use in unapproved indication,6,17112259
1,22.1,Hypotension,6,17112259
0,22.1,Blood pressure increased,6,17112260
0,22.1,Vertigo,4,17112266
0,22.1,Thrombotic thrombocytopenic purpura,4,17112290
0,22.1,Confusional state,1,17112301
1,22.1,Hemiparesis,2,17112301
2,22.1,Cerebrovascular accident,2,17112301
0,22.1,Death,5,17112311
0,22.1,Muscular weakness,4,17112317
0,22.1,Organising pneumonia,1,17112324
0,22.1,Inflammatory myofibroblastic tumour,1,17112328
1,22.1,Benign vaginal neoplasm,1,17112328
0,22.1,Laboratory test abnormal,6,17112355
1,22.1,Metastases to lung,6,17112355
0,22.1,Asthma,5,17112400
0,22.1,Alopecia,6,17112450
1,22.1,Decreased appetite,6,17112450
0,22.1,Infection,1,17112496
1,22.1,Delirium,6,17112496
0,22.1,Diarrhoea,5,17112497
1,22.1,Multiple organ dysfunction syndrome,5,17112497
2,22.1,Acute kidney injury,5,17112497
3,22.1,Thrombosis,5,17112497
4,22.1,Sepsis,5,17112497
5,22.1,Dehydration,5,17112497
6,22.1,Neutropenia,5,17112497
0,22.1,Hyperbilirubinaemia,2,17112501
0,22.1,Death,5,17112511
0,22.1,Prostate cancer,5,17112517
0,22.1,White blood cell count abnormal,6,17112546
0,22.1,Arthralgia,3,17112602
1,22.1,Haemoglobin decreased,6,17112602
2,22.1,Myalgia,3,17112602
3,22.1,Hip arthroplasty,1,17112602
4,22.1,Nausea,3,17112602
5,22.1,Malaise,6,17112602
6,22.1,Urinary tract infection,6,17112602
7,22.1,Peripheral swelling,3,17112602
8,22.1,Product dose omission,6,17112602
9,22.1,Joint swelling,3,17112602
0,22.1,Dementia,6,17112617
1,22.1,Malignant neoplasm progression,6,17112617
2,22.1,Microangiopathy,6,17112617
3,22.1,Neurological symptom,6,17112617
0,22.1,Atrial fibrillation,4,17112772
1,22.1,Cardiac failure,4,17112772
0,22.1,Anaemia,3,17112787
0,22.1,Back pain,3,17112830
1,22.1,Decreased appetite,6,17112830
2,22.1,Decreased immune responsiveness,3,17112830
3,22.1,Headache,6,17112830
4,22.1,Fatigue,3,17112830
5,22.1,General physical health deterioration,6,17112830
6,22.1,Depressed mood,6,17112830
0,22.1,Cerebellar syndrome,3,17112846
1,22.1,Vertigo,3,17112846
2,22.1,Dysmetria,3,17112846
3,22.1,Gait disturbance,3,17112846
0,22.1,Intestinal obstruction,1,17112872
1,22.1,Wound infection,1,17112872
2,22.1,Large intestine perforation,1,17112872
0,22.1,Immobile,6,17112897
0,22.1,Respiratory tract infection,1,17112908
0,22.1,Coagulopathy,5,17112926
1,22.1,Overdose,5,17112926
2,22.1,Dandy-Walker syndrome,5,17112926
3,22.1,Uterine leiomyoma,5,17112926
4,22.1,Erythema,5,17112926
5,22.1,Toxic epidermal necrolysis,5,17112926
6,22.1,Anaemia,5,17112926
7,22.1,Febrile neutropenia,5,17112926
8,22.1,Menorrhagia,5,17112926
9,22.1,Thrombocytopenia,5,17112926
10,22.1,Sopor,5,17112926
11,22.1,Heart valve incompetence,5,17112926
12,22.1,Hepatic failure,5,17112926
13,22.1,Hypertension,5,17112926
14,22.1,Asthma,5,17112926
15,22.1,Altered state of consciousness,5,17112926
16,22.1,Skin toxicity,5,17112926
17,22.1,Skin exfoliation,5,17112926
18,22.1,Hyperglycaemia,5,17112926
19,22.1,Lymphadenopathy,5,17112926
20,22.1,Hepatic steatosis,5,17112926
21,22.1,Polyneuropathy,5,17112926
0,22.1,Diabetes mellitus,6,17112937
1,22.1,Cataract,6,17112937
2,22.1,Obesity,6,17112937
3,22.1,Hypertension,6,17112937
4,22.1,Vomiting,6,17112937
5,22.1,Nausea,6,17112937
6,22.1,Pain,6,17112937
0,22.1,Hallucination,3,17112997
1,22.1,Delusion,3,17112997
2,22.1,Confusional state,3,17112997
3,22.1,Off label use,1,17112997
0,22.1,Nausea,1,17113013
1,22.1,Pyrexia,1,17113013
2,22.1,Vomiting,1,17113013
3,22.1,Back pain,1,17113013
0,22.1,Haemolytic anaemia,3,17113023
1,22.1,Pancytopenia,3,17113023
0,22.1,Depressed level of consciousness,5,17113042
1,22.1,Hypercalcaemia,1,17113042
0,22.1,Febrile neutropenia,1,17113043
0,22.1,Tumour associated fever,1,17113088
0,22.1,Death,5,17113089
0,22.1,Death,5,17113138
1,22.1,Product use in unapproved indication,6,17113138
0,22.1,Chemotherapy,6,17113162
1,22.1,Dyspnoea,1,17113162
2,22.1,Tremor,1,17113162
0,22.1,Subacute cutaneous lupus erythematosus,1,17113222
1,22.1,Fatigue,6,17113222
2,22.1,Intentional product use issue,6,17113222
0,22.1,Pneumonia,2,17113276
0,22.1,Interstitial lung disease,1,17113299
0,22.1,Cardiomyopathy,2,17113323
0,22.1,Disease progression,5,17113353
1,22.1,Colorectal cancer recurrent,5,17113353
0,22.1,Therapy partial responder,6,17113371
1,22.1,Neutropenia,6,17113371
2,22.1,Neurotoxicity,6,17113371
3,22.1,Thrombocytopenia,6,17113371
0,22.1,Death,5,17113375
1,22.1,Myasthenia gravis,3,17113375
0,22.1,Duodenal perforation,1,17113419
0,22.1,Interstitial lung disease,1,17113433
0,22.1,Hepatic function abnormal,6,17113457
0,22.1,Colitis ulcerative,2,17113539
0,22.1,Haematochezia,3,17113549
0,22.1,Pneumonia,3,17113555
0,22.1,Amylase increased,6,17113564
0,22.1,Hepatic atrophy,6,17113576
1,22.1,Disease progression,6,17113576
0,22.1,Death,5,17113596
0,22.1,Skin disorder,1,17113597
0,22.1,Intentional product use issue,6,17113622
1,22.1,Off label use,6,17113622
2,22.1,Death,5,17113622
0,22.1,Drug hypersensitivity,6,17113626
1,22.1,Pneumonia,3,17113626
0,22.1,Interstitial lung disease,4,17113632
0,22.1,Disease progression,5,17113639
1,22.1,Drug ineffective,6,17113639
2,22.1,Angiopathy,6,17113639
0,22.1,Blood creatinine increased,6,17113690
0,22.1,Interstitial lung disease,5,17113693
0,22.1,Pneumonitis,5,17113718
1,22.1,Acute respiratory distress syndrome,5,17113718
0,22.1,Decreased appetite,6,17113720
1,22.1,Vomiting,6,17113720
2,22.1,Constipation,6,17113720
3,22.1,Alopecia,6,17113720
4,22.1,Dysphonia,6,17113720
5,22.1,Nausea,6,17113720
6,22.1,Hypertension,6,17113720
7,22.1,Neutropenia,6,17113720
0,22.1,Febrile neutropenia,1,17113721
0,22.1,Dermatitis allergic,2,17113777
0,22.1,Pancytopenia,6,17113890
1,22.1,Febrile neutropenia,1,17113890
0,22.1,Tumour pseudoprogression,6,17113936
0,22.1,Swelling,6,17113952
1,22.1,Pain in jaw,6,17113952
2,22.1,Osteonecrosis,3,17113952
0,22.1,Necrosis,1,17113965
0,22.1,Chest pain,1,17114000
1,22.1,Drug hypersensitivity,1,17114000
2,22.1,Dyspnoea,1,17114000
3,22.1,Feeling hot,1,17114000
4,22.1,Flushing,1,17114000
0,22.1,Interstitial lung disease,2,17114014
1,22.1,Malignant neoplasm progression,5,17114014
2,22.1,Toxic epidermal necrolysis,1,17114014
0,22.1,Malaise,3,17114048
1,22.1,Constipation,3,17114048
0,22.1,Taste disorder,3,17114074
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,2,17114074
2,22.1,Paraesthesia,3,17114074
0,22.1,Gastric cancer,3,17114077
1,22.1,Headache,6,17114077
2,22.1,Pericardial effusion,6,17114077
3,22.1,Blood pressure increased,1,17114077
4,22.1,Vitamin D decreased,1,17114077
5,22.1,Second primary malignancy,3,17114077
6,22.1,Blood creatinine increased,1,17114077
7,22.1,Blood iron decreased,1,17114077
0,22.1,White blood cell count decreased,1,17114078
1,22.1,Bone marrow failure,6,17114078
0,22.1,Fatigue,3,17114082
1,22.1,Myalgia,3,17114082
2,22.1,Memory impairment,3,17114082
3,22.1,Weight increased,3,17114082
4,22.1,Tremor,3,17114082
5,22.1,Muscle strength abnormal,3,17114082
6,22.1,Erectile dysfunction,3,17114082
7,22.1,Back pain,1,17114082
0,22.1,Fistula,6,17114083
1,22.1,Mucosal inflammation,6,17114083
2,22.1,Nausea,6,17114083
3,22.1,Electrolyte imbalance,6,17114083
4,22.1,Thrombocytopenia,6,17114083
5,22.1,Vomiting,6,17114083
6,22.1,Neurotoxicity,6,17114083
7,22.1,Musculoskeletal toxicity,6,17114083
8,22.1,Hypertension,6,17114083
9,22.1,Neutropenia,6,17114083
10,22.1,Toxicity to various agents,6,17114083
11,22.1,Skin toxicity,6,17114083
12,22.1,Diarrhoea,6,17114083
13,22.1,Anaemia,6,17114083
14,22.1,Leukopenia,6,17114083
15,22.1,Proteinuria,6,17114083
16,22.1,Pain,6,17114083
17,22.1,Pneumonitis,6,17114083
18,22.1,Hypertriglyceridaemia,6,17114083
